Risk factors associated with MRSA

References

• Joshi S , Ray P , Manchanda V , et al . Methicillin resistant Staphylococcus aureus (MRSA) in India: prevalence & susceptibility pattern. Indian J Med Res. 2013;137(2): 363–9.
   PubMedGoogle Scholar
• Layton MC , Hierholzer WJ Jr , Patterson JE . The evolving epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital. Infect Control Hosp Epidemiol. 1995;16: 12–7.10.2307/30140995
   PubMed Web of Science ®Google Scholar
• Srinivasan S , Sheela D , Shashikala, MR , et al . Risk factors and associated problems in the management of infections with methicillin resistant Staphylococcus aureus . Indian J Med Microbiol. 2006;24: 182–5.
   PubMedGoogle Scholar
• Lowmen W . Vancomycin versus teicoplanin in the treatment of serious Gram-positive infectio s: what do the minimum inhibitory concentration data tell us? South Afr J Infect Dis. 2014;29(3): 114–7.
   Google Scholar
• Kishore S , Verma D , Siddique ME . Comparison of In-vitro activities of Linezolid and Vancomycin against Staphylococcus aureus isolated from a tertiary care hospital. J Clin Diagn Res. 2014 May;8(5): 12.
   PubMedGoogle Scholar
• Winn, W , Elmer W , editors. (2006) Koneman’s color atlas and textbook of diagnostic microbiology. Philadelphia : Williams & Wilkins.
   Google Scholar
• CLSI .2013. Performance standards for antimicrobial susceptibility testing. CLSI approved standard M100-S23. Wayne : Clinical and laboratory Standards institute.
   Google Scholar
• Mehta AP , Rodrigues C , Sheth K , et al . Control of methicillin resistant Staphylococcus aureus in a tertiary care centre. A five wear study. J Med Microbiol 1998;16: 31–4.
   Google Scholar
• Krishna PS , Arora VM , Parthasarathy P , et al . Incresing antimicrobial resistance among clinical isolates of Methicillin resistant Staphylococcus aureus (MRSA) from a Delhi hospital. J Academy Clin Microbiolog 2002;4: 61–5.
   Google Scholar
• Sharma JB , Ahmad GU . Characterisation of Mrticillin resistant strains and risk factors for acquisition in a teaching hospital in northeast India. IJMM. 2010;28(2): 127–9.
   Google Scholar
• Chitnis S , Katara G , Hemvani N , et al . In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India. Indian J Med Res.. 2013 Jan;137(1): 191–6.
   PubMedGoogle Scholar
• Huang YT , Liao CH , Teng LJ , et al . Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan, Clin Microbiol Infect. 2008;14 (2):124–9.
   PubMed Web of Science ®Google Scholar
• Gemmella CG . Susceptibility of a variety of clinical isolates to linezolid: a European inter-country comparison. J Antimicrob Chemother. 2001;48(1): 47–52.10.1093/jac/48.1.47
   PubMed Web of Science ®Google Scholar
• Rajaduraipandi K , Mani KR , Panneerselvam K , et al . Prevalence and antimicrobial susceptibility pattern of Methicillin resistant Staphylococcus aureus: a multicenter study. Indian J Med Microbiol. 2006;24: 34–8.10.4103/0255-0857.19892
   PubMedGoogle Scholar
• Chang S , Sievert DM , Hageman JC , et al . Infections with Vancomycin resistant Staphylococcus aureus containing the Van A resistance gene. New Eng J Med. 2003;348: 1342–7.10.1056/NEJMoa025025
   PubMed Web of Science ®Google Scholar
• Rybak M , Lomaestro B , Rotshcafer JC , et al . Therapeutic monitoring of vancomycin in adult-patients: a consensus review of the American society of Health-system Pharmacists, the Infectious Diseases Society of American and the Society of Infectious Disease Pharmacists. Am J Heath Syst Pharm. 2009;66: 82–98.10.2146/ajhp080434
   PubMedGoogle Scholar
• Weigelt J , Kaafarani HM , Itani KM , et al . Linezolid eradicates MRSA better than vancomycin from surgical-site infections. Am J Surg. 2004;188: 760–6.10.1016/j.amjsurg.2004.08.045
   PubMed Web of Science ®Google Scholar
• Weigelt J , Itani KM , Stevens D , et al . Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother. 2005;49: 2260–6.10.1128/AAC.49.6.2260-2266.2005
   PubMed Web of Science ®Google Scholar
• Cepeda JA , Whitehouse T , Cooper B , et al . Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicenter study. J Antimicrob Chemother. 2004;53: 345–55.10.1093/jac/dkh048
   PubMed Web of Science ®Google Scholar
• Svetitsky S , Leibovisi L , Paul M . Comparative efficacy and safety of Vancomycin versus Teicoplanin :Systematic review and meta analysis. Antimicrob Agents Chemother. 2009;53(10): 4069–79.10.1128/AAC.00341-09
   PubMed Web of Science ®Google Scholar
• Lin C , Bayer A , Cosgrove SE , et al . Clinical practice guidelines by the Infectious Diseases Society of America for the management of methicillin resistant staphylococcus aureus infections in children and adults. Clin Infect Dis. 2011;52: 1–38.
   PubMed Web of Science ®Google Scholar